Navigation Links
Bionovo to Present at the Piper Jaffray Healthcare Conference
Date:12/2/2008

EMERYVILLE, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective drugs in the areas of women's health and cancer, announced that Isaac Cohen, Chairman and CEO of Bionovo, will be presenting an overview of the Company at the 20th Annual Piper Jaffray Health Care Conference at 8 a.m. EST on December 3, 2008. The event will be held at the New York Palace Hotel in New York City.

The presentation will be webcast and can be viewed via Bionovo's website at http://bionovo.com/investors/events or http://www.piperjaffray.com/conferences.

A webcast replay will become available shortly after the presentation ends and will continue to be accessible for a short period via Bionovo's website.

About Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking State
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
2. Bionovo Reports Third Quarter 2008 Financial Results
3. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
4. Bionovo to Present at Canaccord Adams Global Growth Conference
5. Bionovo Reports Second Quarter 2008 Financial Results
6. Bionovo to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
7. Bionovo Develops a High Throughput LC-MS/MS Method for Simultaneous Quantification of Multiple Bioactive Compounds
8. Bionovo Reports First Quarter 2008 Financial Results
9. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
10. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
11. Louis Drapeau Joins Bionovos Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 CEL-SCI Corpora...enneth S. Rosenthal, Professor of Immunology and M...ege of Medicine and Pharmacy, reported on work con...veland Clinic and CEL-SCI on CEL-SCI,s LEAPS vacci...GTCbio Vaccine: "All Things Considered" Conference...
(Date:11/8/2009)... VIEW, Calif. Nov. 5, 2009 Complete Genomics, a ...today announced publication of a report in the jou...encing platform, including analysis of sequence da...les cost for these three genomes sequenced on the ...rom $8,005 for 87x coverage to $1,726 for 45x cove...
(Date:11/6/2009)...s., Nov. 6 Myriant Technologies LL... and manufacturer of renewable bio-chemicals, Uhd...ogy provider Uhde GmbH, one of the world,s leading...ed an alliance for the engineering, procurement &a...nic Acid plants based on renewable feedstocks. Th...
(Date:11/6/2009)...lif., Nov. 6 Intarcia Therapeutics...CA 650 (DUROS® continuous delivery of exenati...t the Ninth Annual Diabetes Technology Meeting in ...m.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ...ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces ...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...healthcare giants, GE Healthcare and St. Jude Med...o develop a state-of-the-art cardiovascular ultras... disease. , ,Under terms of the agreement, the hea... integrated intracardiac echocardiography (ICE) im...s worldwide, enabling minimally invasive therapies...
...palities around the Midwest looking for new ways t...raditional approaches of bringing in developers to...thers are trying to entice businesses with tax inc...thin their municipalities. , ,This is a common pr...iving away tax incentives and adjusting building c...
...Wisconsin Angel Network , hoping to add another di...its new ePlan system to enable companies to use ri...r would-be investors. , ,The ePlan, which uses Med...d to help companies reach more investors with less...lane ticket, businesses seeking angel funding can ...
Other Biology Technology:GE, St. Jude to collaborate on visualization technology 2Electronic signs for municipalities: Las Vegas or lost revenues? 2Electronic signs for municipalities: Las Vegas or lost revenues? 3Electronic signs for municipalities: Las Vegas or lost revenues? 4Angel network introduces ePlan 2
(Date:11/9/2009)...duction method that begins by soaking corn kernels...s of ethanol and more usable co-products, giving e...about 20 percent. , "The conventional ethanol pr...stillers dried grains with soluble, it doesn,t hav...ois Agricultural Engineer Esha Khullar. "Whereas i...
(Date:11/9/2009)...ncer, the hopeful news is that pediatric survival ...e bad newstreatments that enable survival often ca...who have reached puberty currently have an opportu...g cancer treatment, they may have their semen froz...ever, do not produce sperm, although their testicu...
(Date:11/9/2009)...partment of Energy (DOE) has announced plans to fu...gham (UAB) School of Engineering on technologies t...ough the capture and permanent safe storage, or se...is in collaboration with Southern Company, the par...E through the 2009 American Recovery and Reinvestm...
Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 1Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 2Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 3Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 1Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 1Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 3
... 2008) -- On Nov. 8 and 9, Morgan Stanley Children...niversity Medical Center will host an "Innovations...att New York, which will feature lectures by inter...al research, genetic findings and stem cell therap... about congenital and primary immunodeficiencies; ...
...tudy led by investigators from Massachusetts Gener...look at how interactions between genes underlie a ...ory. Functional imaging studies reveal how a comb...ted with reduced activity of important brain struc...controls. The report has been released online in ...
...th expert Daniel Hayes, Ph.D., of the New York Cit... that a form of vitamin D could be one of our body... of radiation. Writing in the International Journ...ol, the active form of vitamin D, may protect us f...fe protective agent before or after a low-level nu...
Other Biology News:Innovations in Pediatric Medicine International Conference brings together pediatrics experts 2Interaction between gene variants may alter brain function in schizophrenia 2Could vitamin D save us from radiation? 2
Endotoxin Free Water from Mo Bio Laboratories, Inc.
Chicken Anti-GBL Polyclonal Antibody, Unconjugated from ProSci, Inc
DEPC water from Mo Bio Laboratories, Inc.
Chicken Anti-TLN2 Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: